161 related articles for article (PubMed ID: 36435159)
1. The signal transducer and activator of transcription 3 at the center of the causative gene network of the hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2023 Feb; 80():102264. PubMed ID: 36435159
[TBL] [Abstract][Full Text] [Related]
2. Hyper-IgE syndrome, 2021 update.
Minegishi Y
Allergol Int; 2021 Oct; 70(4):407-414. PubMed ID: 34419355
[TBL] [Abstract][Full Text] [Related]
3. Inherited human ZNF341 deficiency.
Béziat V; Fieschi C; Momenilandi M; Migaud M; Belaid B; Djidjik R; Puel A
Curr Opin Immunol; 2023 Jun; 82():102326. PubMed ID: 37080116
[TBL] [Abstract][Full Text] [Related]
4. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.
Béziat V; Li J; Lin JX; Ma CS; Li P; Bousfiha A; Pellier I; Zoghi S; Baris S; Keles S; Gray P; Du N; Wang Y; Zerbib Y; Lévy R; Leclercq T; About F; Lim AI; Rao G; Payne K; Pelham SJ; Avery DT; Deenick EK; Pillay B; Chou J; Guery R; Belkadi A; Guérin A; Migaud M; Rattina V; Ailal F; Benhsaien I; Bouaziz M; Habib T; Chaussabel D; Marr N; El-Benna J; Grimbacher B; Wargon O; Bustamante J; Boisson B; Müller-Fleckenstein I; Fleckenstein B; Chandesris MO; Titeux M; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Meyts I; Di Santo JP; Hovnanian A; Somer A; Ozen A; Rezaei N; Chatila TA; Abel L; Leonard WJ; Tangye SG; Puel A; Casanova JL
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29907691
[TBL] [Abstract][Full Text] [Related]
5. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
6. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
7. Hyper-IgE syndrome with STAT3 mutation: a case report in Mainland China.
Xie L; Hu X; Li Y; Zhang W; Chen L
Clin Dev Immunol; 2010; 2010():289873. PubMed ID: 20490271
[TBL] [Abstract][Full Text] [Related]
8. Genetic origins of hyper-IgE syndrome.
Minegishi Y; Karasuyama H
Curr Allergy Asthma Rep; 2008 Sep; 8(5):386-91. PubMed ID: 18682102
[TBL] [Abstract][Full Text] [Related]
9. Clinical Manifestations and Genetic Analysis of 17 Patients with Autosomal Dominant Hyper-IgE Syndrome in Mainland China: New Reports and a Literature Review.
Wu J; Chen J; Tian ZQ; Zhang H; Gong RL; Chen TX; Hong L
J Clin Immunol; 2017 Feb; 37(2):166-179. PubMed ID: 28197791
[TBL] [Abstract][Full Text] [Related]
10. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
[TBL] [Abstract][Full Text] [Related]
12. [Hyper-IgE syndrome with mutation in STAT3 gene - case report and literature review].
Heropolitańska-Pliszka E; Pietrucha B; Mikołuć B; Bernatowska E
Med Wieku Rozwoj; 2009; 13(1):19-25. PubMed ID: 19648655
[TBL] [Abstract][Full Text] [Related]
13. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
14. Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome.
Renner ED; Rylaarsdam S; Anover-Sombke S; Rack AL; Reichenbach J; Carey JC; Zhu Q; Jansson AF; Barboza J; Schimke LF; Leppert MF; Getz MM; Seger RA; Hill HR; Belohradsky BH; Torgerson TR; Ochs HD
J Allergy Clin Immunol; 2008 Jul; 122(1):181-7. PubMed ID: 18602572
[TBL] [Abstract][Full Text] [Related]
15. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
16. Destructive pulmonary staphylococcal infection in a boy with hyper-IgE syndrome: a novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene (p.Y657S).
Liu JY; Li Q; Chen TT; Guo X; Ge J; Yuan LX
Eur J Pediatr; 2011 May; 170(5):661-6. PubMed ID: 21107604
[TBL] [Abstract][Full Text] [Related]
17. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.
Goel S; Sahu S; Minz RW; Singh S; Suri D; Oh YM; Rawat A; Sehgal S; Saikia B
Front Immunol; 2018; 9():1080. PubMed ID: 29868029
[TBL] [Abstract][Full Text] [Related]
18. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
19. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
20. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]